The Federal Court of Justice (Bundesgerichtshof) is scheduled to address a related case against a different vaccine company on 9 March. This will be the court’s first decision in a similar matter, underscoring the importance of maintaining rigorous oversight of pharmaceutical products in Germany.
Stuttgart Court Rejects BioNTech Appeal Over Vaccine Verdict
